The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127755291 12775529 1 I 20160826 20160916 20160923 20160923 EXP PHHY2016FR129086 SANDOZ 40.13 YR M Y 0.00000 20160923 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127755291 12775529 1 PS AMOXICILLIN + CLAVULANATE POTASSIUM AMOXICILLINCLAVULANATE POTASSIUM 1 Intravenous (not otherwise specified) 1 G, ONCE/SINGLE AT 11.40 AM Y 65063 1 G 1X
127755291 12775529 2 SS AMOXICILLIN + CLAVULANATE POTASSIUM AMOXICILLINCLAVULANATE POTASSIUM 1 Intravenous (not otherwise specified) 2 G, ONCE/SINGLE AT 08.40 PM Y 65063 2 G 1X
127755291 12775529 3 SS ATRACURIUM HOSPIRA ATRACURIUM 1 Intravenous (not otherwise specified) 40 MG, ONCE/SINGLE Y 0 40 MG 1X
127755291 12775529 4 SS PROPOFOL. PROPOFOL 1 Intravenous (not otherwise specified) 300 MG, ONCE/SINGLE Y 0 300 MG 1X
127755291 12775529 5 SS KETAMINE RENAUDIN KETAMINE 1 Intravenous (not otherwise specified) 40 MG, ONCE/SINGLE Y 0 40 MG 1X
127755291 12775529 6 SS SUFENTANIL SUFENTANIL 1 Intravenous (not otherwise specified) 20 MG, ONCE/SINGLE Y 0 20 MG 1X
127755291 12775529 7 SS MIDAZOLAM MIDAZOLAMMIDAZOLAM HYDROCHLORIDE 1 Intravenous (not otherwise specified) 2 MG, ONCE/SINGLE Y 0 2 MG 1X

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127755291 12775529 1 Antibiotic prophylaxis
127755291 12775529 3 General anaesthesia
127755291 12775529 4 General anaesthesia
127755291 12775529 5 General anaesthesia
127755291 12775529 6 General anaesthesia
127755291 12775529 7 General anaesthesia

Outcome of event

Event ID CASEID OUTC COD
127755291 12775529 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127755291 12775529 Hypotension
127755291 12775529 Tachycardia
127755291 12775529 Urticaria

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127755291 12775529 1 20160826 20160826 0
127755291 12775529 2 20160826 20160826 0
127755291 12775529 3 20160826 20160826 0
127755291 12775529 4 20160826 20160826 0
127755291 12775529 5 20160826 20160826 0
127755291 12775529 6 20160826 20160826 0
127755291 12775529 7 20160826 20160826 0